Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating the efficacy and safety of M518101 in plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis [Phase 3]
Phase 3 long-term study evaluating the safety and efficacy of M518101 in subjects with plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis [Phase 3]
Pfizer's Phase 3 long-term study of CP-690,550 (tofacitinib) in adults with moderate-to-severe plaque psoriasis and/or psoriatic arthritis h…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept [Phase 4]
Phase 4 trial comparing autoinjector preferences in patients with rheumatoid arthritis and plaque psoriasis treated with etanercept; results…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens [Phase 3]
Phase 3 trial evaluating different doses and dosing regimens of subcutaneous secukinumab (AIN457) in adults with moderate-to-severe chronic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients [Phase 2]
Phase IIa study evaluating multiple IV doses of AbGn-168H in adults with moderate to severe chronic plaque psoriasis; the study has complete…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacodynamics of Dalazatide (ShK-186) over 4 weeks in adults with active plaque ps…
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study [NA]
This clinical trial update presents results from a bilateral pilot study comparing NB-UVB phototherapy with and without a topical LCD treatm…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis [Phase 2]
Phase 2 study investigating the mechanism of action of tofacitinib (CP-690,550) in the skin of adults with moderate to severe chronic plaque…
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis [Phase 1, Phase 2]
This is a completed Phase 1/2 trial comparing AIN457 (secukinumab) to placebo in adults with moderate-to-severe stable plaque psoriasis. Res…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003) [Phase 2]
Phase 2 study to determine the optimal dose of tildrakizumab for moderate-to-severe chronic plaque psoriasis completed with posted results i…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis [Phase 2]
Phase 2 study of AIN457 (secukinumab) for moderate-to-severe plaque psoriasis completed, with results posted in 2015. Sponsor: Novartis Phar…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
A Phase 2 trial evaluating Apo805K1 in adults with moderate-to-severe chronic plaque psoriasis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis [Phase 2]
Novartis completed a Phase II efficacy study of a single-dose regimen of AIN457 for chronic plaque psoriasis. Results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis [Phase 2]
Phase 2 dose-ranging study of AIN457 (efalizumab) in adults with chronic plaque psoriasis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis [Phase 2]
A Phase 2 trial evaluating a multiple-loading dose regimen in patients with chronic plaque psoriasis has completed and posted results in 201…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated adding modulators of homocysteine to adalimumab therapy for moderate to severe plaque psoriasis; the st…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 trial results update showing safety and efficacy of adalimumab in treating plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
This update reports completion of a Phase 2 dose-finding study of MT-1303 in adults with moderate to severe chronic plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020) [Phase 1]
Phase 1 study evaluating safety, tolerability and pharmacokinetics of MK-0873 after patch application in healthy participants and participan…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis. [Phase 3]
Phase 3 trial update for oral apremilast (CC-10004) evaluating safety and effectiveness in moderate to severe plaque psoriasis; study comple…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating oral apremilast for moderate to severe plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis [Phase 2]
Phase 2 clinical trial evaluating safety and pharmacokinetics of apremilast in recalcitrant plaque psoriasis has completed with results post…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis [Phase 3]
Pfizer conducted a one-year Phase 3 trial to evaluate the effects and safety of CP-690,550 (tofacitinib) in adults with moderate to severe c…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation [Phase 4]
This Phase 4 open-label trial assessed the safety and effectiveness of adalimumab for moderate to severe plaque psoriasis in the Russian Fed…